Notify me when Vivo Capital IX, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SVA | Sinovac Biotech Ltd. | Common Shares, $0.001 par value per share | 6.3% | $293,522,587 | 4,539,456 | Vivo Capital IX, LLC | 17 Mar 2025 | ||
| TIL | Instil Bio, Inc. | Common stock, par value $ 0.000001 per share | 4.5% | $7,169,276 | 292,743 | Vivo Capital IX, LLC | 30 Jun 2025 | ||
| SERA | Sera Prognostics, Inc. | Class A common stock, par value $ 0.0001 per share | 4.5% | $5,528,974 | 1,650,440 | Vivo Capital IX, LLC | 31 Mar 2025 | ||
| IOBT | IO Biotech, Inc. | Common stock, par value $0.001 per share | 0% | $0 | 0 | Vivo Capital IX, LLC | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|